DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing...

詳細記述

書誌詳細
主要な著者: Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H
フォーマット: Journal article
言語:English
出版事項: 2010